Adiposs is a Swiss biotech start-up company developing medical imaging products and technologies for early detection of cachexia
Cachexia is a fatal body wasting syndrome characterized by involuntary weight loss, muscle atrophy, fatigue, weakness and loss of appetite.
9 million patients diagnosed with cancer every year are affected by cachexia. It dramatically reduces their quality of life, response and tolerance to cancer therapies and survival.
1 in 4 cancer patients dies as a consequence of cachexia and not cancer itself, yet doctors do not know when cachexia begins.
ImageBAT is a new CT contrast agent which enables early detection of cachexia before patients lose body weight. Detection of cachexia will be fast, pain-free and available in every hospital worldwide. ImageBAT will give millions of cancer patients an improved quality of life and a better chance to survive cancer.
Andrej is the Chief Executive Officer and co-founder of Adiposs. He is the co-inventor of ImageBAT. Andrej has worked in the field of diagnostic imaging for over 10 years leading multidisciplinary teams and projects in academic and start-up environment. He is a co-author of 30+ scientific papers and owner of several patents in the fields of diagnostics, photodynamic therapy and nanotechnology.
Justyna is the Chief Operating Officer and co-founder of Adiposs. She has over 10 years of extensive business, finance and competitive intelligence experience. She has spent a big part of her professional life working at KPMG where she provided audit, advisory and due diligence services to a wide range of public and private companies in multiple jurisdictions.
Copyright © 2019 Adiposs , Switzerland - All Rights Reserved.